Offer - Urjas Oil for just ₹ 1 X
Imalek 400 Mg Tablet is a commercial drug that is prescribed in the form of Capsule. Primarily, it is used for the treatment of Chronic Myelogenous Leukemia. Imalek 400 Mg Tablet also has some secondary and off-label uses. These are listed below.
The right dosage of Imalek 400 Mg Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Imalek 400 Mg Tablet as well, which are listed below. Normally, these side effects of Imalek 400 Mg Tablet are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Imalek 400 Mg Tablet's effect is Severe during pregnancy and Moderate for lactating mothers. Warnings related to Imalek 400 Mg Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Some other conditions that can be affected by Imalek 400 Mg Tablet are listed in the contraindications section below.
Additionally, Imalek 400 Mg Tablet may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Imalek 400 Mg Tablet is considered not safe while driving, and is not addictive.
Imalek 400 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
2 - 12 years (Child) |
|
13 - 18 years (Adolescent) |
|
Is the use of Imalek 400 Mg Tablet safe for pregnant women?
Imalek shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Imalek 400 Mg Tablet safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Imalek. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Imalek 400 Mg Tablet on the Kidneys?
There can be some harmful effects on your kidneys after taking Imalek. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Imalek 400 Mg Tablet on the Liver?
Side effects of Imalek rarely affect the liver.
What is the effect of Imalek 400 Mg Tablet on the Heart?
The heart can be affected by Imalek. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Imalek 400 Mg Tablet unless your doctor advises you to do so -
Is this Imalek 400 Mg Tablet habit forming or addictive?
No, you will not get addicted to Imalek 400 Mg Tablet.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Imalek 400 Mg Tablet can make you feel drowsy.
Is it safe?
Imalek 400 Mg Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Imalek 400 Mg Tablet in mental disorders is not effective.
Interaction between Food and Imalek 400 Mg Tablet
You can take Imalek 400 Mg Tablet with food.
Interaction between Alcohol and Imalek 400 Mg Tablet
Due to lack of research, there is no information about the side effects of taking Imalek 400 Mg Tablet with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gleevec (imatinib mesylate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 674-676
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 869